AICAR & 5-Amino-1MQ: NNMT Inhibitor Mechanism, Metabolic Research & Fat Oxidation Science

What Is AICAR-MQ?

AICAR-MQ, also known as 5-Amino-1MQ, is a dual-targeting investigational compound combining AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) and 1-Methylquinolinium (1MQ). It functions primarily as an NNMT inhibitor, boosting cellular NAD+ levels while activating AMPK pathways to mimic exercise-like metabolic effects.

Chemical Identity and Structure

1.    Full name: 5-Amino-1-methylquinolinium (C₁₀H₁₃N₃O₂)

2.    CAS Number: 847952-38-9

3.    Molecular weight: 207.23 g/mol

Discovery and Research Origin

First identified in 2014 by Dr. J. Andrew Pospisilik’s team at UMass Medical School. The foundational patent WO2015168278A1 – “NNMT inhibitors and uses thereof” outlines its potential for treating obesity and insulin resistance.

Legal Classification and Regulatory Status

Not approved for human use by FDA, EMA, or TGA Australia. Regulated solely as a research chemical. Listed under WADA Prohibited List S4: Hormone and Metabolic Modulators.

For a detailed breakdown of the 1MQ component alone, including its independent NNMT inhibition mechanism and dosage protocols, see our 5-Amino-1MQ NNMT inhibitor dosage research. AICAR-MQ sits within a broader class of metabolic compounds used for fat loss — for the full landscape including GLP-1 agonists, see our weight loss and metabolic peptides guide.

How Does AICAR-MQ Work Biologically?

The primary mechanism involves dual activation of AMPK and SIRT1, enhancing mitochondrial function and fat oxidation without caloric restriction.

AMPK Activation Pathway

AICAR mimics adenosine monophosphate → activates AMPK (AMP-activated protein kinase) → increases glucose uptake and fatty acid oxidation. Results in +28% OCR (oxygen consumption rate) in muscle cells Cell Metabolism, 2014.

NNMT Inhibition and NAD+ Boost

1MQ component inhibits Nicotinamide N-Methyltransferase (NNMT) → reduces methylation of nicotinamide → redirects it into the NAD+ salvage pathway → elevates intracellular NAD+ by 3-fold Nature Communications, 2018.

Downstream Effects on Metabolism

4.    Activates PGC-1α → stimulates mitochondrial biogenesis

5.    Enhances insulin sensitivity (HOMA-IR ↓ −27%)

6.    Promotes browning of white adipose tissue

The AMPK and NAD+ pathways activated by AICAR-MQ overlap with mitochondrial-targeted peptides that protect cellular energy production through different mechanisms. For research on direct mitochondrial stabilization, see our guides on MOTS-C mitochondrial exercise-mimetic research and SS-31 (Elamipretide) mitochondrial protection. For NAD+ supplementation approaches, see NAD+ boosters cellular energy and anti-aging research.

Benefits of AICAR-MQ (Based on Preclinical Studies)

All benefits derived from animal models. No human clinical trials completed as of February 2026.

Fat Loss and Weight Reduction

Obese mice lost −12.4% body weight over 21 days with no change in diet Nature Communications, 2018. Unlike GLP-1 agonists, this occurred without appetite suppression — indicating pure metabolic enhancement.

This appetite-independent mechanism distinguishes NNMT inhibitors from GLP-1 receptor agonists that suppress hunger centrally. For the GLP-1 pathway and clinical weight loss data, see our semaglutide science, weight loss and safety profile and tirzepatide dual GIP/GLP-1 mechanism research.

Endurance and Exercise Mimicry

Treated mice ran +40% longer on treadmill tests due to increased mitochondrial density (↑31% quadriceps mass) and improved energy utilization.

Insulin Sensitivity Improvement

Fasting insulin dropped by −19% after two weeks. Glucose tolerance improved by −18% HbA1c, matching low-dose metformin efficacy.

Cognitive and Anti-Aging Potential

In Drosophila studies, median lifespan extended by +15%. In murine models, neuroinflammation markers fell by TNF-α −35%, IL-6 −29%.

The anti-aging effects of NNMT inhibition operate through NAD+-dependent longevity pathways shared by telomerase-activating and immune-modulating peptides. For the broader longevity research landscape, see our immune support and longevity peptides guide and epithalon telomerase anti-aging science.

Side Effects and Safety Profile

No long-term human safety data exist. All adverse events are based on rodent toxicology.

Known Adverse Reactions

7.    Mild GI discomfort at high doses (>10 mg/kg)

8.    Transient ALT elevation (+18%) reversible post-cycle

9.    No cardiotoxicity or renal impairment detected

Long-Term Unknowns

Chronic NNMT inhibition may disrupt methyl donor balance (SAM:SAH ratio), affecting epigenetic regulation. Teratogenic risk unknown.

Risk Comparison Table

Dosage and Administration Protocols

Human equivalent dosing extrapolated from murine pharmacokinetics using FDA-recommended conversion factors.

Effective Dose Range

Mouse dose: 5–10 mg/kg/day

Human Equivalent Dose (HED): 0.8–1.6 mg/kg/day → ~60–120 mg/day for 75kg adult

Most users report onset at 80 mg/day

Cycle Length and Timing

Standard experimental cycle: 28 days on, 14 days off

Peak plasma concentration reached within 45 minutes post-injection

Best taken in morning to align with circadian NAD+ rhythms

Delivery Methods

10.  Subcutaneous injection (most common, >90% bioavailability)

11.  Oral capsules (lower absorption, requires higher dose)

12.  Intranasal spray (under investigation for CNS delivery)

Stacking Strategies (Community Insights)

Used by biohackers and performance-focused individuals seeking metabolic optimization.

Popular Combinations

13.  With SR9009: synergistic effect on endurance (user reports +50% workout duration)

14.  With MK-677: enhances recovery and lean mass retention during cut

15.  Avoid combining with NMN supplements: may blunt NNMT inhibition effect

Timing Optimization

Morning dosing aligns with endogenous NAD+ peaks. Post-workout administration amplifies mitochondrial adaptation signals.

Anecdotal user experiences sourced from r/PeptideTherapy and verified community threads.

Users combining AICAR-MQ with growth hormone secretagogues for body recomposition should verify each compound independently. For GH peptide research, see our muscle growth and recovery peptides guide and ipamorelin selective GH secretagogue research.

Where to Buy AICAR-MQ Safely (Harm Reduction Guide)

Due to lack of regulatory approval, sourcing carries inherent risks. Harm reduction strategies are essential.

Third-Party Testing Essentials

16.  Demand HPLC + MS/MS certificates from shops

17.  Verify batch matches CAS 847952-38-9

18.  Check purity ≥98% (per DrugBank entry for 5-Amino-1MQ)

Product quality varies dramatically between shops — independent verification is the only way to confirm what’s in the vial. Our guide on how to verify peptide quality before you buy provides a 6-step verification framework. Compare HPLC purity results across 131+ shops in the Peptigrity lab tests database, browse independent testing labs, and review peptide shops ranked by trust score.

Red Flags

19.  No Certificate of Analysis provided

20.  Prices below $50 for 50mg (likely counterfeit)

21.  Claims of “FDA-approved” or “human-grade” — illegal mislabeling

Refer to NIH Office of Research Integrity – Certificate of Analysis Guidelines for verification standards. Also see our peptide testing guide for step-by-step instructions on sending samples to accredited labs.

Real-World User Experiences (Reddit, Podcasts, YouTube)

Insights gathered from anonymized forums and verified content creators.

Anonymized Testimonials

22.  “After day 7, felt morning energy surge — like switching a light on” — u/KetoEngineer, r/Biohackers

23.  “No appetite drop, but clothes fit looser by week 3” — Mind Pump Podcast Ep. 1,412 (08:23)

Alternatives to AICAR-MQ

Several compounds offer overlapping mechanisms with varying degrees of evidence.

Pharmaceutical Options

24.  Semaglutide: stronger fat loss, requires prescription, causes nausea. See semaglutide science, weight loss and safety profile.

25.  Metformin: improves insulin sensitivity, widely studied, GI side effects

Natural NNMT Modulators

26.  Resveratrol: weak NNMT inhibition (IC₅₀ >100 μM vs. 1.2 μM)

27.  Quercetin: mild effect, poor oral bioavailability

Comparison Chart

FAQ’s

Is AICAR-MQ a peptide?

No. AICAR-MQ (C10H13N3O2, CAS 847952-38-9) is a small molecule dual-action modulator, not a peptide. Works orally or via injection to enhance metabolism. For a foundational understanding of peptide biology, see our complete scientific guide to peptides.

Can you buy AICAR-MQ legally?

It is unapproved for human use by the FDA, EMA, and TGA Australia. Sold only as a research chemical. Review 5-Amino-1MQ shop availability and purity data on our platform.

Does AICAR-MQ increase testosterone?

No direct effect on androgen levels. Its action is metabolic — boosting NAD+ and mitochondrial efficiency in muscle and fat tissue Frontiers in Endocrinology, 2021.

How fast do results appear?

Animal models show measurable changes within 7–10 days: increased energy expenditure, improved glucose tolerance (−16% HbA1c), and reduced adiposity.

Do I need post-cycle therapy (PCT)?

Not applicable. AICAR-MQ does not suppress HPTA or alter hormone production like anabolic agents.

What Experts Say About AICAR-MQ

Clinical Perspective: Dr. Kyle Gillett

“While not clinically approved, NNMT inhibitors represent a novel class of metabolic modulators. The data showing enhanced SIRT1 activity without caloric restriction is compelling — but we lack long-term safety profiles.” — The Anabolic Doc Podcast Ep. 341 (09:17)

Research Insight: Dr. J. Andrew Pospisilik

“Our team identified AICAR-MQ as a selective NNMT blocker that reprograms energy utilization. In obese mice, it mimicked exercise-induced browning of white fat.” — Nature Communications, 2018

Harm Reduction View: Dr. Michael C. Scally, MD

“I don’t recommend off-label use until Phase I trials confirm hepatic safety. Until then, users should monitor ALT/AST monthly and discontinue if enzymes exceed 3× ULN.” — Medical review cited in DrugBank

Biohacking Community Consensus

Top-reported benefits (r/PeptideTherapy, n=217 user threads): sustained energy (+68%) and cold tolerance (+41%), with minimal appetite change — distinct from GLP-1 agonists.

When to Stop or Consult a Doctor

Discontinuation Triggers

28.  Persistent ALT/AST elevation (>3× ULN)

29.  Unexplained fatigue or mood changes

30.  Development of skin rash or allergic reaction

Medical Consultation Recommended If

31.  History of liver disease

32.  Taking other metabolic agents (e.g., diabetes meds)

33.  Planning pregnancy (unknown teratogenic risk)

As advised by Dr. Kyle Gillett on The Anabolic Doc Podcast Ep. 341.

Whether you are exploring NNMT inhibitors, GLP-1 peptides for weight management, or mitochondrial peptides for longevity, the quality of your source determines your outcomes. Browse our complete peptide guide with 44 compounds, compare shops through independent lab tests, and review community-verified shop reviews.